In Week of Mar 28, 2026, Dhampur Bio Organics Ltd (Sugar) is outperforming Nifty 500 with +44.5% relative strength. Fundamentals: Average. On a 10-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Feb 22, 2026
What: 11.26% sugar margins vs 3.11% YoY driving PAT recovery
Impact: +₹100 Cr revenue
“Management reported sugar segment EBIT margin expansion to 11.26% from 3.11% YoY”
What: Biofuels turned profitable with 3.16% EBIT margin vs loss last year
Impact: +₹20 Cr revenue
“Biofuels & Spirits segment reported EBIT of ₹2.62 cr with 3.16% margin vs (0.96)% loss YoY”
Earnings deceleration risks from management commentary
Trigger: Volume decline exceeds 20% with current price realization
Impact: -200 bps margin impact
Management view: Sugar sales volume decreased to 73,282 tons from 89,252 tons YoY, but realization increased 6.72% per ton.
Monitor: Sugar sales volume vs realization
Trigger: ROCE remains below 10% for extended period
Management view: Not directly addressed in available transcripts
Monitor: ROCE trajectory
Key quotes from recent conference calls
“Sugar segment delivered significant margin expansion during Q3 FY26 with EBIT Margin at 11.26% versus 3.11% year-on-year — Management”
“The company operates 29,500 TCD sugarcane crushing capacity and 95.5 MW renewable energy capacity across three manufacturing facilities — Management”
“Board approved unaudited Q3 and nine-month FY26 results and exploration of mycoprotein venture with Planetary SA — Management”
Forward-looking targets from management for N/A
Key Milestones
• Mycoprotein venture exploration
• Sugar margin sustainability
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +5% | +6% | Stable |
| PAT (Net Profit) | +343% | -47% | Accelerating |
| OPM | 9.0% | +600 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Feb 22, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Dhampur Bio Organics Ltd's latest quarterly results (Dec 2025) show
Dhampur Bio Organics Ltd's profit is growing with an accelerating trend.
Dhampur Bio Organics Ltd's revenue growth trend is stable.
Dhampur Bio Organics Ltd's operating margin is volatile.
Dhampur Bio Organics Ltd's long-term compounding rates
Dhampur Bio Organics Ltd's earnings growth is accelerating with improving on a sequential basis.
Dhampur Bio Organics Ltd's trailing twelve month (TTM) performance
Dhampur Bio Organics Ltd appears significantly overvalued based on our fair value analysis.
Dhampur Bio Organics Ltd's current PE ratio is 29.7x.
Dhampur Bio Organics Ltd's current PE is 29.7x.
Dhampur Bio Organics Ltd's price-to-book ratio is 0.7x.
Dhampur Bio Organics Ltd is rated Average with a fundamental score of 46.56/100. This score is calculated from objective financial metrics
Dhampur Bio Organics Ltd has a debt-to-equity ratio of N/A.
Dhampur Bio Organics Ltd's return ratios over recent years
Dhampur Bio Organics Ltd's operating cash flow is positive (FY2025).
Dhampur Bio Organics Ltd's current dividend yield is 1.18%.
Dhampur Bio Organics Ltd's shareholding pattern (Dec 2025)
Dhampur Bio Organics Ltd's promoter holding has remained stable recently.
Dhampur Bio Organics Ltd has been outperforming Nifty 500 for 10 consecutive weeks, indicating consistent outperformance.
Dhampur Bio Organics Ltd is an established outperformer with 10 weeks of consecutive Nifty 500 outperformance.
Dhampur Bio Organics Ltd has 2 key growth catalysts identified from recent earnings analysis
Dhampur Bio Organics Ltd has 2 key risks worth monitoring
In Q3 FY26, Dhampur Bio Organics Ltd's management highlighted
Dhampur Bio Organics Ltd's management has provided the following forward guidance for N/A
Based on quantitative research signals, here is why Dhampur Bio Organics Ltd may be worth studying
Dhampur Bio Organics Ltd investment thesis summary:
Dhampur Bio Organics Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
